What Is Pulmonary Arterial Hypertension (PAH)?



pulmonary emphysema treatment :: Article Creator

Drugs For Treatment Of Chronic Obstructive Pulmonary Disease

Are you searching for medications to treat 'Chronic Obstructive Pulmonary Disease'? Welcome to this section, which serves as a repository for medications that are relevant to the treatment of Chronic Obstructive Pulmonary Disease. The page includes both the generic and brand names and can be an invaluable resource for healthcare professionals and individuals who wish to get an insight on different medication options. Click on a medication below to view details including brand names, prices, dosages, side effects, and administration guidelines. Additionally, a FAQs section is available for each medication, addressing popular inquiries and providing deeper insights into its use for Chronic Obstructive Pulmonary Disease management. We recommend consulting your doctor to verify the information presented on this page or for any additional clarifications. Advertisement Brand Names and Generic Names of Drugs for Treatment of Chronic Obstructive Pulmonary Disease Aclidinium Bromide Oral Inhalation Aclidinium Bromide Oral Inhalation is used for the long-term maintenance treatment of bronchospasm or sudden constriction of the airways associated with chronic obstructive pulmonary disease (COPD), chronic bronchitis, and emphysema or damaged air sacs in the lungs. Albuterol and Ipratropium Albuterol or salbutamol and Ipratropium combination is prescribed to prevent wheezing, difficulty in breathing, chest tightness, and coughing in chronic obstructive pulmonary disease (COPD) such as chronic bronchitis (swelling of the air passages that lead to the lungs) and emphysema (damage to the air sacs in the lungs). Advertisement Arformoterol Tartrate Inhalation Arformoterol Tartrate Inhalation is a long-acting beta-agonist bronchodilator, prescribed for chronic obstructive pulmonary disease (COPD). Trade Names : Benralizumab Benralizumab is a type of monoclonal antibody which is prescribed as an add-on maintenance treatment for treating severe eosinophilic asthma in patients 12 years of age and older. Doxofylline Doxofylline is an antitussive, prescribed for asthma and Chronic Obstructive Pulmonary Disease (COPD). Trade Names : More... Advertisement Erdosteine Erdosteine is a mucolytic agent, prescribed for chronic obstructive bronchitis. Trade Names : Etofylline Etofylline is a bronchodilator. Trade Names : Gemifloxacin Gemifloxacin is a fluoroquinolone antibiotic. Trade Names : More... Indacaterol Indacaterol is a long-acting beta-agonist bronchodilator, prescribed for chronic obstructive pulmonary disease (COPD) symptoms. Ozagrel Ozagrel is used as an antiplatelet drug for conditions like cerebral ischemia (reduced blood supply to a part of the brain) and to treat bronchial asthma. Pirfenidone Pirfenidone is prescribed for treating idiopathic pulmonary fibrosis which is a severe irreversible disease marked by a progressive decline in lung function. Trade Names : Roflumilast Roflumilast is a phosphodiesterase type 4 (PDE4) inhibitor, prescribed for lung inflammation in patients with chronic obstructive pulmonary disease (COPD). Salbutamol Salbutamol is a bronchodilator, prescribed for asthma and chronic obstructive pulmonary disease (COPD). Trade Names : More... Tiotropium Tiotropium is an anticholinergic agent, prescribed for chronic obstructive pulmonary disease (COPD), including bronchitis and emphysema. Trade Names : Search for Drugs: For Related Medical Condition Search for Drugs: For Related Medical Condition Suggested Readings on Chronic Obstructive Pulmonary Disease Encyclopedia section of medindia gives general info about Lung Cancer Smoking is the most important preventable cause of cancer in the world. Smoking causes many diseases and affects the overall health of smokers. Nearly 2.4 million deaths every year are attributable to air pollution. Air pollutants may be solid particles, liquid droplets or gases. Proper planning methods should be adopted to reduce air pollution. Emphysema is a chronic obstructive pulmonary disease, marked by alveolar damage and reduced air flow to lungs leading to breathlessness and cough. What is laryngeal papillomatosis and are you at risk? Find out how this condition affects us, and learn about the symptoms it causes and how it can be treated. Find out how smoking increases risk for throat cancer and the use of laryngectomy, which is a surgical procedure to remove the larynx and ways to restore voice. The lungs are our organs of respiration. It is within these, that exchange of gases takes place. Hyperventilation is a deep or fast irregular breathing often caused by anxiety or panic. Causes of hyperventilation include anxiety, emotional stress. Chronic Obstructive Pulmonary Disease (COPD) infographic illustrates the information on the alarming rise of the lung disease that affects 329 million people worldwide. Hypoxia is the term used to denote a deficiency in the amount of oxygen reaching the tissues.



Comments

Post a Comment

Popular posts from this blog

Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor

Image
Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor Posted: 11 Jul 2019 12:00 AM PDT For patients with severe hypoxemia with pulmonary hypertension or right heart dysfunction, inhaled epoprostenol through high-flow nasal cannula increases oxygenation, according to a study published in Pharmaceutics . The researchers of this retrospective study assessed the effect of inhaled epoprostenol using a high-flow nasal cannula on oxygenation and future mechanical ventilation in patients with hypoxemia comorbid with pulmonary hypertension or right heart dysfunction in an intensive care unit setting. A chart review was completed on adult patients who were admitted into the respiratory care department of the Rush University Medical Center for severe hypoxemia between July 2015 and April 2018 and treated with inha...
Read more

Novitium's Generic Sildenafil for PAH Treatment Approved by FDA - Pulmonary Hypertension News

Image
Novitium's Generic Sildenafil for PAH Treatment Approved by FDA - Pulmonary Hypertension News Novitium's Generic Sildenafil for PAH Treatment Approved by FDA - Pulmonary Hypertension News Growing Doubt, Uncertainty Over PDE5i Use in Left Heart Disease - Medscape AnMed Health gains national recognition through the Pulmonary Hypertension Association - WSPA.com Novitium's Generic Sildenafil for PAH Treatment Approved by FDA - Pulmonary Hypertension News Posted: 12 Jun 2019 05:00 AM PDT The U.S. Food and Drug Administration (FDA) has approved Novitium Pharma 's generic sildenafil for oral suspension at a dose of 10 mg/mL for the treatment of pulmonary arterial hypertension (PAH). This product, which had been designated a competitive generic therapy by the FDA, is the first approved generic equivalent to Pfizer 's Revatio , a vasodilator agent that induces blood ves...
Read more

Analysis: Large pharma companies do little new drug innovation - STAT

Image
Analysis: Large pharma companies do little new drug innovation - STAT Analysis: Large pharma companies do little new drug innovation - STAT Gene Therapy Takes Center Stage at 2019 NORD Summit - Pulmonary Hypertension News People Living With Type 2 Diabetes Want Information and Empathy From Their Doctors More Than New Medications - PRNewswire Analysis: Large pharma companies do little new drug innovation - STAT Posted: 10 Dec 2019 01:51 AM PST L arge pharmaceutical companies oppose legislation being considered by Congress to lower the prices of prescription drugs. Reducing their revenues, they contend, will reduce their investment in drug development and the discovery of new medicines, and thus lead to a decline in drug innovation. If that argument is credible, there should be evidence to show that the large pharmaceutical companies are responsible for discovering innovative new drugs. To test that claim, we examined the...
Read more